Works matching IS 09291903 AND DT 2009 AND VI 16 AND IP 3

Results: 9

Intravenous injection of siRNA directed against hypoxia-inducible factors prolongs survival in a Lewis lung carcinoma cancer model.

Published in:

Cancer Gene Therapy, 2009, v. 16, n. 3, p. 195, doi. 10.1038/cgt.2008.71

By:

Kamlah, F.;
Eul, B. G.;
Li, S.;
Lang, N.;
Marsh, L. M.;
Seeger, W.;
Grimminger, F.;
Rose, F.;
Hänze, J.

Publication type:

Article

Exploiting the tumor microenvironment in the development of targeted cancer gene therapy.

Published in:

Cancer Gene Therapy, 2009, v. 16, n. 3, p. 279, doi. 10.1038/cgt.2008.72

By:

Dougherty, G. J.;
Dougherty, S. T.

Publication type:

Article

Enhanced oncolytic potency of vesicular stomatitis virus through vector-mediated inhibition of NK and NKT cells.

Published in:

Cancer Gene Therapy, 2009, v. 16, n. 3, p. 266, doi. 10.1038/cgt.2008.74

By:

Altomonte, J.;
Wu, L.;
Meseck, M.;
Chen, L.;
Ebert, O.;
Garcia-Sastre, A.;
Fallon, J.;
Mandeli, J.;
Woo, S. L. C.

Publication type:

Article

Oncolytic adenovirus retargeted to Delta-EGFR induces selective antiglioma activity.

Published in:

Cancer Gene Therapy, 2009, v. 16, n. 3, p. 256, doi. 10.1038/cgt.2008.75

By:

Piao, Y.;
Jiang, H.;
Alemany, R.;
Krasnykh, V.;
Marini, F. C.;
Xu, J.;
Alonso, M. M.;
Conrad, C. A.;
Aldape, K. D.;
Gomez-Manzano, C.;
Fueyo, J.

Publication type:

Article

Therapy of head and neck squamous cell carcinoma with replicative adenovirus expressing tissue inhibitor of metalloproteinase-2 and chemoradiation.

Published in:

Cancer Gene Therapy, 2009, v. 16, n. 3, p. 246, doi. 10.1038/cgt.2008.76

By:

McNally, L. R.;
Rosenthal, E. L.;
Zhang, W.;
Buchsbaum, D. J.

Publication type:

Article

MicroRNA profile analysis of human prostate cancers.

Published in:

Cancer Gene Therapy, 2009, v. 16, n. 3, p. 206, doi. 10.1038/cgt.2008.77

By:

Tong, A. W.;
Fulgham, P.;
Jay, C.;
Chen, P.;
Khalil, I.;
Liu, S.;
Senzer, N.;
Eklund, A. C.;
Han, J.;
Nemunaitis, J.

Publication type:

Article

Imaging of cationic multifunctional liposome-mediated delivery of COX-2 siRNA.

Published in:

Cancer Gene Therapy, 2009, v. 16, n. 3, p. 217, doi. 10.1038/cgt.2008.79

By:

Mikhaylova, M.;
Stasinopoulos, I.;
Kato, Y.;
Artemov, D.;
Bhujwalla, Z. M

Publication type:

Article

The effects of trichostatin A on the oncolytic ability of herpes simplex virus for oral squamous cell carcinoma cells.

Published in:

Cancer Gene Therapy, 2009, v. 16, n. 3, p. 237, doi. 10.1038/cgt.2008.81

By:

Katsura, T.;
Iwai, S.;
Ota, Y.;
Shimizu, H.;
Ikuta, K.;
Yura, Y.

Publication type:

Article

Combined silencing of K-ras and Akt2 oncogenes achieves synergistic effects in inhibiting pancreatic cancer cell growth in vitro and in vivo.

Published in:

Cancer Gene Therapy, 2009, v. 16, n. 3, p. 227, doi. 10.1038/cgt.2008.82

By:

Shi, X. H.;
Liang, Z. Y.;
Ren, X. Y.;
Liu, T. H.

Publication type:

Article